Study Details

Back to Search Results

A study to evaluate isavuconazonium sulfate for the treatment of invasive aspergillosis (IA) or invasive mucormycosis (IM) in pediatric participants

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT03816176

Astellas Study ID

The unique identification code given by the study sponsor.

9766-CL-0107

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

2018-003975-36

Follow Trial

Condition

Fungal Infections

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

1 years - 17 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Aug 2019 - Dec 2022

Masking

None (Open Label)

Enrollment number

31

A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Subjects

Study summary

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate isavuconazonium sulfate for the treatment of invasive aspergillosis (IA) or invasive mucormycosis (IM) in pediatric participants? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site ES34003

Madrid, Spain, 28009

St Jude Children's Res Hospital

Memphis, United States, 38105

Children's Mercy Hospital

Kansas City, United States, 64108

Site BE32002

Leuven, Belgium, 3000

Children's National Medical Center

Washington, United States, 20010

University of California - Los Angeles

Los Angeles, United States, 90095

Nicklaus Children's Hospital

Miami, United States, 33155

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, United States, 60611

Children's Hospital of Orange County

Orange, United States, 92868

Miller Children's Hospital

Long Beach, United States, 90806

SUNY Upstate Medical University

Syracuse, United States, 13210

Site ES34001

Madrid, Spain, 28041

Site DE49001

Munster, Germany, 48149

Site BE32001

Gent, Belgium, 9000

University of Louisville

Louisville, United States, 40202

Site ES34002

Barcelona, Spain, 8035

Cincinnati Children's Hospital

Cincinnati, United States, 45229

Children's Hospital, Los Angeles

Los Angeles, United States, 90027

Children's Hospital, LSUHSC, New Orleans

New Orleans, United States, 70118

Site DE49006

Essen, Germany, 45147

Site GB44002

Leeds, United Kingdom, LS1 9EX

Duke University

Durham, United States, 27705

Site GB44004

Cardiff, United Kingdom, CF14 4XW

Detriot Medical Center-Children's Hospital of Michigan

Detroit, United States, 48201

Site ES34004

Barcelona, Spain, 8950

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo